High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria

Thrombosis and Haemostasis

Volumn 93, Issue 1, 2005, Pages 88-91

  Araten, David J ^a   Thaler, Howard T ^a   Luzzatto, Lucio ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Deep venous thrombosis; Ethnicity; Hypercoagulable states; Paroxysmal Nocturnal Hemoglobinuria (PNH); Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; CHILD; ETHNIC GROUPS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INCIDENCE; LATIN AMERICA; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; THROMBOPHILIA; THROMBOSIS; UNITED STATES;

EID: 12344337648     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-06-0391     Document Type: Article

References (27)

1. Rotoli B, Luzzato L. Paroxysmal Nocturnal Hemoglobinuria. Bailliere's Clin Hematol 1989; 2: 118-38.
2. Socie G, Mary JY, de Gramont A et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996; 348: 573-7.
3. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253-8.
4. Ronne E, Pappot H, Grondahl-Hansen J, et al. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1995; 89: 576-81.
5. Nicholson-Weller A, Spicer DB, Austen KF. Deficiency of the complement regulatory protein, "decay-accelerating facor" on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinura. N Engl J Med 1985; 1091-7.
6. Jin JY, Tooze JA, Marsh JCW, et al. Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paoxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils. Br J Haematol 1997; 96: 493-6.
7. Polley MJ, Nachman RL. Human complement in thrombin-mediated platelet function. J Exp Med 1979; 150: 633-45.
8. Zimmerman TS, Kolb WP. Human platelet-initiated formation and uptake of the C5-9 complex of human complement. J Clin Invest 1976; 57: 203-11.
9. Dixon RH, Rosse WF, Thorpe AM. Mechanism of complement-mediated activation of human blood platelets in vitro. J Clin Invest 1977; 59: 360-8.
10. Devine DV, Siegel RSRWF. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. J Clin Invest 1987; 79: 131-7.
11. Wiedmer J, Hall SE, Ortel TL, et al. Complement-Induced Vesiculation and Exposure of Membrane Prothrombinase Sites in Platelets of Paroxysmal Nocturnal Hemoglobinuria. Blood 1993; 82: 1192-6.
12. Hugel B, Socie G, Vu T, et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999; 93: 3451-6.
13. Sims PJ, Faioni EM, Wiedmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
14. Ott I, Miyagi Y, Miyazaki K, et al. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vascular Biol 2000; 20: 874-82.
15. Ware RE, Hall SE, Rosse WF. Paroxysmal nocturnal hemoglobinuria New Engl J Med 1991; 325: 991-6.
16. Tudela M, Jarque I, Perez-Sirvent ML, et al. Clinical profile and course of paroxysmal nocturnal hemoglobinuria. Sangre 1993; 38: 301-7.
17. Koduri PR, Gowrishnakar S. Paroxysmal nocturnal haemoglobinuria in Indians. Acta Haemtologica 1992; 88: 126-8.
18. Xio-feng L, Tian-ying Y, Xue-yon Y. Characteristics of paroxysmal nocturnal hemoglobinuria in China. Chin Med J 1990; 103: 885-9.
19. Gongora-Biachi RA, Gonzalez-Martinez P, Sosa-Munoz J, et al. Natural history of paroxysmal nocturnal hemoglobinuria in adolescents, adults, and children: the Mexican experience. Sangre 1997; 42: 171-7.
20. Krutrachue M, Wasi P, Na-Nakorn S. Paroxysmal Nocturnal Haemoglobinuria in Thailand with special reference to an association with aplastic anaemia. Br J Haematol 1978; 39: 267-76.
21. Fujioka S, Asai T. Prognostic features of paroxysmal nocturnal hemoglobinuria in Japan. Acta Haematologica Japonica 1989; 52: 1386-94.
22. Araten DJ, Bessler M, McKenzie S, et al. Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia 2002; 2243-8.
23. Antin JH, Ginsburg D, Smith BR, et al. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Blood 1985; 66: 1247-50.
24. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003; 102: 3587-91.
25. McMullin MF, Hillmen P, Jackson J, et al. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. J Intern Med 1994; 235: 85-9.
26. Stein PD, Kayali F, Olson RE. Regional differences in rates of diagnosis and mortality of pulmonary thromboembolism. Am J Cardiol 2004; 93: 1194-7.
27. Stein PD, Kayali F, Olson RE, et al. Pulmonary thromboembolism in Asians/Pacific islanders in the United States: Analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116: 435-42.